APC and cancer: The most common mutation affecting downstream components in the aberrant cancer Wnt/β-catenin signaling pathway is seen in the gene-encoding adenomatous polyposis coli (APC), with such mutations being seen in RNF43-, ZNRF3-, and RSPO3-mediated cancers [23,26,44,45].